CVE detail

CVE-2023-33364 — CVE-2023-33364

Published 2023-08-03 · Modified 2026-06-17 · Vendor supremainc · Product biostar_2 · Source nvd

HIGH

severity

CVSS-derived band

8.8

CVSS v3

0–10 scale

0.0156

EPSS probability

exploitation probability, 30d

73.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.